Screener
Edwards Lifesciences EW Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $241.4M-27.2% | $380.7M+6.8% | $91.2M-76.3% | $290.3M-90.5% | $331.5M-9.2% | ||
| —— | $40.9M+11.7% | $42.7M+0.2% | $39.2M+13.6% | $38.1M-3.8% | ||
| —— | $45.4M+12.9% | $39.2M+23.7% | $41.2M-2.1% | $37.5M-14.6% | ||
| —— | $43.8M-84.4% | $450.9M— | $573.7M+63.1% | $290.2M-21.9% | ||
| —— | $64.9M+15.9% | $97.4M+95.6% | $57.5M+10.8% | $49.3M-42.3% | ||
| —— | $6.3M— | $15M-45.3% | $1.5M-94.4% | $48.3M— | ||
| —— | -$92.8M-209% | -$198.3M— | -$427.8M-116% | -$172.1M-238% | ||
| —— | $421.8M+63.1% | $40.6M-59.4% | $588.7M-34.7% | $5.5M-96.5% | ||
| —— | -$451.2M-74.9% | -$11.4M— | -$740.1M+24.2% | $0+100% | ||
| —— | -$492M-647% | —— | -$595.2M-129% | $141.2M-67.1% |
FAQ
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
